Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Myeloperoxidase Antikörper

MPO Reaktivität: Human WB, IP, IHC (fro), EIA Wirt: Maus Monoclonal 266-6K1 unconjugated
Produktnummer ABIN1108340
  • Target Alle Myeloperoxidase (MPO) Antikörper anzeigen
    Myeloperoxidase (MPO)
    Reaktivität
    • 173
    • 63
    • 55
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 129
    • 79
    • 1
    • 1
    • 1
    Maus
    Klonalität
    • 120
    • 91
    Monoklonal
    Konjugat
    • 90
    • 32
    • 30
    • 12
    • 11
    • 10
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Myeloperoxidase Antikörper ist unkonjugiert
    Applikation
    • 121
    • 87
    • 63
    • 61
    • 31
    • 28
    • 27
    • 19
    • 14
    • 14
    • 14
    • 13
    • 10
    • 8
    • 7
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human.
    Aufreinigung
    Purified
    Klon
    266-6K1
    Isotyp
    IgG1
    Top Product
    Discover our top product MPO Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0,1 mg/mL
    Buffer
    PBS, 0.02 % sodium azide, 0,1 % BSA
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C.
  • Target
    Myeloperoxidase (MPO)
    Andere Bezeichnung
    Myeloperoxidase (MPO Produkte)
    Synonyme
    mKIAA4033 antikoerper, MPO antikoerper, LOC100335032 antikoerper, POX2' antikoerper, XPOX2' antikoerper, mpo antikoerper, mpo-A antikoerper, pmr-1 antikoerper, pmr1 antikoerper, pox2 antikoerper, xpox2 antikoerper, myeloperoxidase antikoerper, myeloperoxidase L homeolog antikoerper, MPO antikoerper, Mpo antikoerper, LOC100335032 antikoerper, mpo.L antikoerper
    Hintergrund
    MPO is abundantly present in azurophilic granules of polymorphonuclear neutrophils. It is an important enzyme used during phagocytic lysis of engulfed foreign particles which takes part in the defence of the organism through production of hypochlorous acid (HOCl), a potent oxidant. MPO is rapidly released by activated polymorphonuclear neutrophils. Involvement of MPO has been described in numerous diseases such as atherosclerosis, lung cancer, Alzheimer's disease and multiple sclerosis. Autoimmune antibodies to MPO are involved in Wegeners disease. Since the discovery of MPO deficiency, initially regarded as rare and restricted to patients suffering from severe infections, MPO has more attracted clinical attention. In experimental studies antibodies to MPO can be used for various purposes ranging from flow cytometric analysis to detection of polymorphonuclear neutrophils in tissue sections.Synonyms: MPO
    Gen-ID
    9606
    UniProt
    P05164
    Pathways
    Chromatin Binding
Sie sind hier:
Kundenservice